RecruitingNot ApplicableNCT06129890

Neuromodulation in Patients With Neuropathic Pain and Depression.

Neuromodulation in Patients With Neuropathic Pain and Depression: a Cross-over Study Between Two Targets in Transcranial Magnetic Stimulation, the Primary Motor Cortex and the Dorsolateral Prefrontal Cortex.


Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Enrollment

60 participants

Start Date

Apr 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

High-frequency repetitive transcranial magnetic stimulation of the primary motor cortex has shown its effect on refractory neuropathic pain, and rTMS of the dorsolateral prefrontal cortex is commonly used for treatment-resistant depression. The treatment for patients suffering from neuropathic pain and depression, concomitantly, still needs to be studied, as there are some specificities in both symptoms and brain functional MRI.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether repetitive transcranial magnetic stimulation (rTMS) — a non-invasive brain stimulation technique — can help reduce both neuropathic pain (nerve pain) and depression at the same time in patients who have both conditions simultaneously. **You may be eligible if:** - You have chronic neuropathic pain (central or peripheral nerve pain present for more than 6 months), rated at least 4 out of 10 in intensity - Your pain occurs at least 4 days a week and has not been fully relieved by recommended medications - Your pain medications have been stable for at least one month - You have been diagnosed with a current depressive episode - Your neurologist has recommended motor cortex rTMS - You are covered by social security **You may NOT be eligible if:** - You have a contraindication to rTMS or MRI (e.g., a pacemaker, epilepsy, metal clips in the brain, certain implants, or claustrophobia) - Your neuropathic pain is from a progressive disease (HIV, cancer, or systemic illness) - You abuse drugs or psychoactive substances - You are under 18 or cannot understand informed consent - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERepetitive transcranial magnetic stimulation (rTMS) - M1/DLPFC

Repetitive transcranial magnetic stimulation (rTMS) is a treatment technique involving the induction of an electrical current on the surface of the cortex by applying a magnetic field to the scalp. This field is generated using a stimulation loop controlled by a robotic arm linked to a neuronavigation system. rTMS of M1 then rTMS of DLPFC.

DEVICERepetitive transcranial magnetic stimulation (rTMS) - DLPFC/M1

Repetitive transcranial magnetic stimulation (rTMS) is a treatment technique involving the induction of an electrical current on the surface of the cortex by applying a magnetic field to the scalp. This field is generated using a stimulation loop controlled by a robotic arm linked to a neuronavigation system. rTMS of DLPFC then rTMS of M1.


Locations(1)

CHU de Saint-Etienne

Saint-Etienne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06129890


Related Trials